Tag: GPs
Latest articles
Clover and GSK collaborate on coronavirus vaccine candidate
Clover Biopharmaceuticals, a China based global clinical-stage biotechnology company focused on developing novel and transformative biologic therapies, announced that it has entered into a...
NHS Discharge Medicines Service to help patients avoid hospital readmission
From July, the NHS Discharge Medicines Service will come into action meaning hospitals will be able to refer patients who would benefit from extra...
First patients receive gene therapy for blindness on NHS
The first patients have begun gene therapy for blindness on the NHS as part of NHS Long Term Plan. Babies born with an inherited retinal...
Popular articles
UK Life Science Opportunity Zones announced
The Office for Life Sciences has announced six new locations that have been awarded the prestigious status of Life Science Opportunity Zone (LSOZ), helping...
First coronavirus clinical data published in The Lancet
The Lancet has published the first coronavirus clinical data from initial cases of the infection in China. The 2019 novel coronavirus (2019-nCoV) appears to cause...
Pharma marketing authorisations, approvals and appraisals
Pf rounds up this week's pharma marketing authorisations, approvals and appraisals, featuring news from the UK, EU, Japan and the USA. UK Kyowa Kirin International announced...
Market Access in practice: do you have a strategy?
This article is a little old... but if you're interested in Market Access we have plenty of new content: July 2018 Market Access Special Edition...
Nurofen launches a 24 hour ibuprofen pain relief patch
Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen. Despite body pain being among the most commonly...